Clinical correlation of gallstone disease in a Chinese population in Taiwan: Experience at Cheng Hsin General Hospital

Table 3 Univariate analysis of associated clinical factors for gallstone disease among 2386 Chinese subjects

		Gallstone disease		Crude OR(95% CI)	Adjusted OR1(95% CI)
		Yes(n=126)	No(n=2260)
Gender	male	59	1176	1.00	-
	female	67	1084	1.23(0.86-1.76)
Age (yr)	<40	11	734	1.00	-
	40-49	19	704	1.80 (0.85-3.81)	-
	50-59	40	464	5.75(2.92-11.32)	-
	60-69	30	222	9.02(4.45-18.29)	-
	≥70	26	136	12.76(6.16-26.43)	-
BMI (Kg/m2)	<24	57	1343	1.00	1.00
	24-27	38	585	1.53(1.00-2.33)	1.36(0.88-2.10)
	≥27	31	33	2.20(1.40-3.46)	2.04(1.28-3.26)
FPG (mg/dL)	<110	93	2007	1.00	1.00
	110-125	10	122	1.77(0.90-3.49)	1.14(0.57-2.28)
	≥126	23	126	3.95(2.42-6.45)	1.95(1.16-3.30)
High SBP	No	93	1885	1.00	1.00
	Yes	33	375	1.78(1.18-2.69)	1.18(0.54-1.33)
High DBP	No	97	1801	1.00	1.00
	Yes	29	459	1.17(0.77-1.80)	0.95(0.61-1.48)
Hypercholeste-rolemia	No	93	1827	1.00	1.00
	Yes	33	433	1.50(1.00-2.26)	1.11(0.72-1.69)
Hypertriglycer-idemia	No	100	1946	1.00	1.00
	Yes	26	314	1.61(1.03-2.52)	1.54(0.97-2.46)
Low HDL	No	122	2052	1.00	1.00
	Yes	4	208	0.32(0.12-0.89)	0.62(0.22-1.73)
High BUN	No	115	2118	1.00	1.00
	Yes	11	142	1.43(0.75-2.71)	0.67(0.34-1.33)
High creatinine	No	118	2214	1.00	1.00
	Yes	8	46	3.26(1.51-7.07)	1.22(0.54-2.78)
Hyperuricemia	No	43	963	1.00	1.00
	Yes	83	1297	1.43(0.98-2.09)	1.18(0.80-1.75)
Higher AST	No	106	2095	1.00	1.00
	Yes	20	165	2.40(1.45-3.97)	1.96(1.16-3.32)
Higher ALT	No	101	1883	1.00	1.00
	Yes	25	377	1.24(0.79-1.94)	1.48(0.92-2.37)
HBV	Negative	113	1975	1.00	1.00
	Positive	13	285	0.80(0.44-1.43)	0.98(0.54-1.78)
Anti-HCV	Negative	123	2204	1.00	1.00
	Positive	3	56	0.96(0.30-3.11)	0.63(0.19-2.07)

¹Adjustment for gender and age.